Brief: MyMD Pharma Investment Company Oravax Medical And Genomma Lab Announce Joint Venture
18/11/2021 14:27
Nov 18 (Reuters) - Genomma Lab Internacional SAB de CV
LABB.MX :
* MYMD PHARMACEUTICALS INVESTMENT COMPANY ORAVAX MEDICAL AND
GENOMMA LAB ANNOUNCE JOINT VENTURE TO DEVELOP AND COMMERCIALIZE
ORAL COVID-19 VACCINE IN MEXICO AND DRIVE BUSINESS DEVELOPMENT
IN LATIN AMERICA
Source text for Eikon: ID:nBwvzvPRa
Further company coverage: LABB.MX
((Reuters.Briefs@thomsonreuters.com;))